Moreover, those strategies may be useful for other purposes such as preventing inappropriate medication use or continuity of medication use.
Explicit criteria for determining potentially inappropriate medication consumption in elderly were elaborated by Beers et al. These lists have been used worldwide to evaluate medical prescriptions but there is little epidemiologic evidence demonstrating negative consequences of inappropriate medication use.
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001.
A further limitation is the heterogeneous, nonstandardized use of inappropriate medication use terminology.
Further effort is needed to develop reliable and valid instruments to measure current inappropriate medication use events in clinical trials.
Accurate assessment of inappropriate medication use events (ie, misuse, abuse, and related events) occurring in clinical trials is an important component in evaluating a medication's abuse potential.
Measurement of inappropriate medication use events (eg, abuse or misuse) in clinical trials is important in characterizing a medication's abuse potential.
To our knowledge, MADDERS is the only system available to comprehensively evaluate inappropriate medication use events prospectively to determine the underlying intent.
Interrater reliability and concurrent validity data are presented, as well as a cut-off score for use in determining inappropriate medication use.
These observations suggest that available instruments are not well suited for assessing current inappropriate medication use within the specific context of clinical trials.
We sought to evaluate the effectiveness of the Fleetwood Model of pharmacy practice on improving resident outcomes and hypothesized that this model would reduce potentially inappropriate medication use, hospitalizations, and death.
